Leite Marcel, Carmona Rita de Cássia Compagnoli, Carraro Emerson, Watanabe Aripuanã Sakurada Aranha, Granato Celso Francisco Hernandes
Grupo Fleury, Automação, São Paulo, São Paulo, Brazil.
Universidade Federal de São Paulo, Departamento de Medicina, Laboratório de Virologia Clínica, Unidade de Doenças Infecciosas, São Paulo, São Paulo, Brazil.
Rev Inst Med Trop Sao Paulo. 2017;59:e45. doi: 10.1590/S1678-9946201759045. Epub 2017 Aug 3.
Rotavirus is the main global cause of severe childhood diarrhoea among children. In 2006, Rotarix® (G1P[8]) was introduced into Brazil's National Immunization Program. The vaccine coverage rate was 84.4% in 2009. Evidences of increasing G2P[4] after 2006 opened up the discussion about the vaccine effectiveness to non-G1 strains. The aim of this study was to identify the circulating rotavirus genotypes in two Brazilian regions during 2009. A total of 223 positive samples by immunochromatography and latex agglutination assay from the Northeast (Bahia/Pernambuco States) and Southeast (São Paulo/Rio de Janeiro States) regions were included in the study. The samples were submitted to genotyping by nested-PCR according to VP7(G) and VP4(P) and 175 samples (78.5%) were able to be characterized. Considering the characterization of VP7, the G-types detected were G1, G2, and G4 in the Northeast, and G2, G3, G5, and G9 in the Southeast. Considering the characterization of VP4, the P-types detected were P[4], P[8], and P[6]/P[9] in the Northeast and the Southeast. The most frequent mixed types found were G2P[4]/G2PNT, G2P6, G1P6 in the Northeast, and G2P[4]/G2PNT, G2P6, G9P8 in the Southeast. Among immunized individuals whose age ranged from 0-4 years, the G2P[4]/G2P[NT] genotype was identified in 91,0% of cases, and among non-immunized individuals of the same age, the G2P[4]/G2P[NT] genotype was identified in 85.7% of the cases. In accordance with the high level of vaccine coverage, the data suggest that the circulation of G2P[4] in these regions had a considerable increase after the introduction of Rotarix®.
轮状病毒是全球儿童严重腹泻的主要病因。2006年,Rotarix®(G1P[8])被纳入巴西国家免疫规划。2009年疫苗覆盖率为84.4%。2006年后G2P[4]毒株增多的证据引发了关于该疫苗对非G1毒株有效性的讨论。本研究的目的是确定2009年巴西两个地区轮状病毒的流行基因型。本研究纳入了来自东北部(巴伊亚州/伯南布哥州)和东南部(圣保罗州/里约热内卢州)地区的223份经免疫层析和乳胶凝集试验检测为阳性的样本。根据VP7(G)和VP4(P)通过巢式PCR对样本进行基因分型,175份样本(78.5%)得以分型。考虑到VP7的分型情况,在东北部检测到的G型为G1、G2和G4,在东南部为G2、G3、G5和G9。考虑到VP4的分型情况,在东北部和东南部检测到的P型为P[4]、P[8]和P[6]/P[9]。在东北部发现的最常见混合基因型为G2P[4]/G2P[NT](81.4%)、G2P[6](5.2%)、G1P[6](5.2%),在东南部为G2P[4]/G2P[NT](78.8%)、G2P[6](8.2%)、G9P[8](4.7%)。在年龄为0至4岁的免疫个体中,91.0%的病例鉴定为G2P[4]/G2P[NT]基因型,在同一年龄段的未免疫个体中,85.7%的病例鉴定为G2P[4]/G2P[NT]基因型。鉴于疫苗的高覆盖率,数据表明在引入Rotarix®后,这些地区G2P[4]的传播有显著增加。